产品
编 号：F745362
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
结构图
CAS No: 1453362-55-4
产品详情
生物活性：
Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity.
体内研究：
Lilotomab (0.5 mg/kg；i.v.；一次) 抑制小鼠肿瘤生长。Animal Model:SCID mice (DOHH2 cell xenografts)
Dosage:0.5?mg/kg
Administration:I.v.; once
Result:Inhibited tumor growth and increased mouse survival.
体外研究：
Lilotomab (0-40 μg/mL; 12 days) 降低 DOHH2 和 Ramos 细胞的克隆形成存活率。Lilotomab (40 μg/mL; 18 h) 诱导 DOHH2 细胞轻微凋亡。
Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity.
体内研究：
Lilotomab (0.5 mg/kg；i.v.；一次) 抑制小鼠肿瘤生长。Animal Model:SCID mice (DOHH2 cell xenografts)
Dosage:0.5?mg/kg
Administration:I.v.; once
Result:Inhibited tumor growth and increased mouse survival.
体外研究：
Lilotomab (0-40 μg/mL; 12 days) 降低 DOHH2 和 Ramos 细胞的克隆形成存活率。Lilotomab (40 μg/mL; 18 h) 诱导 DOHH2 细胞轻微凋亡。
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备